These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives. Ferrarini PL, Badawneh M, Franconi F, Manera C, Miceli M, Mori C, Saccomanni G. Farmaco; 2001 Apr; 56(4):311-8. PubMed ID: 11421260 [Abstract] [Full Text] [Related]
7. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. Mori K, Kikuchi H, Obara Y, Iwashita M, Azumi Y, Kinugasa S, Inatomi S, Oshima Y, Nakahata N. Phytomedicine; 2010 Dec 01; 17(14):1082-5. PubMed ID: 20637576 [Abstract] [Full Text] [Related]
10. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent. Badorc A, Bordes MF, de Cointet P, Savi P, Bernat A, Lalé A, Petitou M, Maffrand JP, Herbert JM. J Med Chem; 1997 Oct 10; 40(21):3393-401. PubMed ID: 9341914 [Abstract] [Full Text] [Related]
11. Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom. Lopez-Johnston JC, de Bosch N, Scannone H, Rodríguez-Acosta A. Ann Hematol; 2007 Dec 10; 86(12):879-85. PubMed ID: 17891398 [Abstract] [Full Text] [Related]
12. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets. Lim H, Kubota K, Kobayashi A, Seki T, Ariga T. Biosci Biotechnol Biochem; 1999 Feb 10; 63(2):298-301. PubMed ID: 10192909 [Abstract] [Full Text] [Related]
13. Effects of ethanol on pathways of platelet aggregation in vitro. Rand ML, Packham MA, Kinlough-Rathbone RL, Fraser Mustard J. Thromb Haemost; 1988 Jun 16; 59(3):383-7. PubMed ID: 3142075 [Abstract] [Full Text] [Related]
14. Quinolizidinyl-benzimidazoles as platelet-antiaggregating agents. Vazzana I, Terranova E, Tasso B, Tonelli M, Piana A, Gastaldi S, Sparatore F. Chem Biodivers; 2008 May 16; 5(5):714-28. PubMed ID: 18493958 [Abstract] [Full Text] [Related]
15. Pyrido[2,3-d]pyrimidin-4(3H)-one derivatives and 1,2,3,4-tetrahydro- pyrido[2,3-d]pyrimidine derivatives: synthesis and in vitro study of their activity against platelet aggregation. Hou G, Gravier D, Casadebaig F, Dupin JP, Bernard H, Boisseau M. Pharmazie; 1995 Nov 16; 50(11):719-22. PubMed ID: 8570668 [Abstract] [Full Text] [Related]
18. New purines with antiplatelet activity. Märschenz K, Rehse K. Arch Pharm (Weinheim); 2006 Mar 16; 339(3):115-22. PubMed ID: 16493596 [Abstract] [Full Text] [Related]
19. [Synthesis and pharmacologic activity of 3-quinolizidine-1'-yl-5-R-indoles]. Boido-Canu C, Boido V, Sparatore F, Sparatore A. Farmaco Sci; 1988 Oct 16; 43(10):801-17. PubMed ID: 3240831 [Abstract] [Full Text] [Related]
20. Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline. Del Maschio A, Bazzoni G, Zatta A, Chen ZM, Dejana E, Prosdocimi M. Eur J Pharmacol; 1990 Oct 23; 187(3):541-5. PubMed ID: 2073928 [Abstract] [Full Text] [Related] Page: [Next] [New Search]